Impact of acute hyperglycemia during primary stent implantation in patients with ST-elevation myocardial infarction

Journal of Cardiology

Volumn 53, Issue 2, 2009, Pages 272-277

  Nakamura, Tomohiro ^a   Ako, Junya ^b   Kadowaki, Tomoko ^a   Funayama, Hiroshi ^a   Sugawara, Yoshitaka ^a   Kubo, Norifumi ^a   Momomura, Shinichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute hyperglycemia; Corrected TIMI frame count; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE; GLUCOSE; HEPARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION; STENT;

ACUTE DISEASE; AGED; BLOOD GLUCOSE; CREATINE KINASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MYOCARDIAL INFARCTION; STENTS;

EID: 62349097436     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.11.011     Document Type: Article

References (37)

1. Oswald G.A., Corcoran S., and Yudkin J.S. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1 (1984) 1264-1267
2. Bellodi G., Manicardi V., Malavasi V., Veneri L., Bernini G., Bossini P., Distefano S., Magnanini G., Muratori L., Rossi G., et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 64 (1989) 885-888
3. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
4. Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., and Cox J.L. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
5. Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang Y., Havranek E.P., and Krumholz H.M. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
6. Meier J.J., Deifuss S., Klamann A., Launhardt V., Schmiegel W.H., and Nauck M.A. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care 28 (2005) 2551-2553
7. Kosuge M., Kimura K., Kojima S., Sakamoto T., Matsui K., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., et al. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 69 (2005) 375-379
8. Ishihara M., Kagawa E., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nakama Y., Maruhashi T., Ookawa K., Dai K., and Aokage Y. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 99 (2007) 1674-1679
9. Deedwania P., Kosiborod M., Barrett E., Ceriello A., Isley W., Mazzone T., and Raskin P. Hyperglycemia and acute coronary syndrome. A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117 (2008) 1610-1619
10. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., Kuroda T., Tanaka K., Masuyama T., Hori M., and Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
11. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985; 312:932-6.
12. Gibson C.M., Cannon C.P., Daley W.L., Dodge Jr. J.T., Alexander Jr. B., Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., and Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
13. van't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., and Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Zwolle Myocardial Infarction Study Group. Circulation 97 (1998) 2302-2306
14. Claeys M.J., Bosmans J., Veenstra L., Jorens P., De Raedt H., and Vrints C.J. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 99 (1999) 1972-1977
15. Kadri Z., Danchin N., Vaur L., Cottin Y., Gueret P., Zeller M., Lablanche J.M., Blanchard D., Hanania G., Genes N., and Cambou J.P. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart 92 (2006) 910-915
16. Weston C., Walker L., and Birkhead J. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart 93 (2007) 1542-1546
17. Oswald G.A., Smith C.C., Betteridge D.J., and Yudkin J.S. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 293 (1986) 917-922
18. Karlsberg R.P., Cryer P.E., and Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 102 (1981) 24-29
19. Petersen C.L., Nielsen J.R., Petersen B.L., and Kjaer A. Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance. Cardiology 100 (2003) 23-28
20. Ito H., Tomooka T., Sakai N., Yu H., Higashino Y., Fujii K., Masuyama T., Kitabatake A., and Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85 (1992) 1699-1705
21. Morishima I., Sone T., Okumura K., Tsuboi H., Kondo J., Mukawa H., Matsui H., Toki Y., Ito T., and Hayakawa T. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36 (2000) 1202-1209
22. Takahashi T., Hiasa Y., Ohara Y., Miyazaki S.I., Mahara K., Ogura R., Miyajima H., Yuba K.I., Suzuki N., Hosokawa S., Kishi K., and Ohtani R. Acute hyperglycemia prevents the protective effect of pre-infarction angina on microvascular function after primary angioplasty for acute myocardial infarction. Heart 94 (2008) 1402-1406
23. Fujimoto K., Hozumi T., Watanabe H., Tokai K., Shimada K., Yoshiyama M., Homma S., and Yoshikawa J. Acute hyperglycemia induced by oral glucose loading suppresses coronary microcirculation on transthoracic Doppler echocardiography in healthy young adults. Echocardiography 23 (2006) 829-834
24. Michishita R., Shono N., Kiyonaga A., Tanaka H., Shindo M., Kasahara T., Tsuruta T., Inoue T., and Node K. Association between silent ST segment depression in exercise electrocardiography and insulin resistance in obese subjects. J Cardiol 49 (2007) 231-239
25. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., and Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
26. Kawano H., Motoyama T., Hirashima O., Hirai N., Miyao Y., Sakamoto T., Kugiyama K., Ogawa H., and Yasue H. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34 (1999) 146-154
27. Pandolfii A., Giaccari A., Cilli C., Alberta M.M., Morviducci L., De Filippis E.A., Buongiorno A., Pellegrini G., Capani F., and Consoli A. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 38 (2001) 71-76
28. Gresele P., Guglielmini G., De Angelis M., Ciferri S., Ciofetta M., Falcinelli E., Lalli C., Ciabattoni G., Davi G., and Bolli G.B. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 41 (2003) 1013-1020
29. Morohoshi M., Fujisawa K., Uchimura I., and Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45 (1996) 954-959
30. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., and Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
31. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., and Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51 (2002) 1076-1082
32. Kersten J.R., Toller W.G., Tessmer J.P., Pagel P.S., and Warltier D.C. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol 281 (2001) H2097-H2104
33. Marfella R., Esposito K., Giunta R., Coppola G., De Angelis L., Farzati B., Paolisso G., and Giugliano D. Circulating adhesion molecules in humans: role of hyperglycemiaand hyperinsulinemia. Circulation 101 (2000) 2247-2251
34. Mehta S.R., Yusuf S., Diaz R., Zhu J., Pais P., Xavier D., Paolasso E., Ahmed R., Xie C., Kazmi K., Tai J., Orlandini A., Pogue J., and Liu L. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-446
35. Cheung N.W., Wong V.W., and McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29 (2006) 765-770
36. Malmberg K., Norhammar A., Wedel H., and Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99 (1999) 2626-2632
37. Malmberg K., Ryden L., Wedel H., Birkeland K., Bootsma A., Dickstein K., Efendic S., Fisher M., Hamsten A., Herlitz J., Hildebrandt P., MacLeod K., Laakso M., Torp-Pedersen C., and Waldenstrom A. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661